-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
CVS Health Corporation Income Statement
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$268.71 B | $292.11 B | $322.47 B | $357.78 B | $372.81 B |
| Cost of Revenue |
|
$219.66 B | $239.99 B | $267.97 B | $303.35 B | $321.41 B |
| Gross Profit |
|
$49.05 B | $52.12 B | $54.50 B | $54.43 B | $51.40 B |
| Research & Development |
|
- | - | - | - | - |
| Selling,General & Administrative |
|
- | - | - | - | -$1.28 B |
| Operating Expense |
|
$35.14 B | $38.81 B | $46.55 B | $40.69 B | $41.61 B |
| Operating Income |
|
$13.91 B | $13.31 B | $7.95 B | $13.74 B | $8.52 B |
| Net Income |
|
$7.18 B | $8.00 B | $4.31 B | $8.34 B | $4.61 B |
CVS Health Corporation Balance Sheet
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$10.85 B | $12.53 B | $15.72 B | $11.46 B | $10.99 B |
| Inventories |
|
$18.50 B | $17.76 B | $19.09 B | $18.03 B | $18.11 B |
| Total Current Assets |
|
$56.37 B | $60.01 B | $65.63 B | $67.86 B | $68.65 B |
| Property,Plant and Equipment |
|
$33.34 B | $32.02 B | $30.75 B | $30.44 B | $28.94 B |
| Goodwill |
|
$79.55 B | $79.12 B | $78.15 B | $91.27 B | $91.27 B |
| Total Assets |
|
$230.72 B | $233.00 B | $228.28 B | $249.73 B | $253.22 B |
| Total Liabilities |
|
$161.01 B | $157.62 B | $156.51 B | $173.09 B | $177.49 B |
| Retained Earnings |
|
$49.64 B | $54.91 B | $56.40 B | $61.60 B | $62.84 B |
| Total Shareholder Equity |
|
$69.39 B | $75.08 B | $71.47 B | $76.46 B | $75.56 B |
| Common Stock |
|
$46.51 B | $47.38 B | $48.19 B | $48.99 B | $49.66 B |
CVS Health Corporation Cash flow
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$4.44 B | $4.49 B | $4.22 B | $4.37 B | $4.60 B |
| Dividends Payout |
|
-$2.62 B | -$2.63 B | -$2.91 B | -$3.13 B | -$3.37 B |
| Capital Expenditures (Capex) |
|
-$2.44 B | -$2.52 B | -$2.73 B | -$3.03 B | -$2.78 B |
| Free Cash Flow (FCF) |
|
$13.43 B | $15.75 B | $13.45 B | $10.40 B | $6.33 B |
CVS Health Corporation Profitability
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$49.05 B | $52.12 B | $54.50 B | $54.43 B | $51.40 B |
| Gross Profit Margin (%) |
|
18.25% | 17.84% | 16.90% | 15.21% | 13.79% |
| Operating Income |
|
$13.91 B | $13.31 B | $7.95 B | $13.74 B | $8.52 B |
| Operating Income Margin (%) |
|
5.18% | 4.56% | 2.47% | 3.84% | 2.28% |
| Net Income |
|
$7.18 B | $8.00 B | $4.31 B | $8.34 B | $4.61 B |
| Net Income Margin (%) |
|
2.67% | 2.74% | 1.34% | 2.33% | 1.24% |
| EBITDA |
|
$17.12 B | $17.53 B | $12.35 B | $18.20 B | $13.68 B |
| EBITDA Margin (%) |
|
6.37% | 6.00% | 3.83% | 5.09% | 3.67% |
CVS Health Corporation Ratios
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
10.35% | 10.66% | 6.03% | 10.91% | 6.11% |
| Return on Assets (ROA) |
|
3.11% | 3.43% | 1.89% | 3.34% | 1.82% |
| Debt to Equity |
|
122.56% | 101.23% | 98.97% | 103.82% | 109.74% |
| Debt to total asset |
|
36.86% | 32.62% | 30.99% | 31.79% | 32.75% |
| Enterprise value to revenue |
|
0.62 | 0.69 | 0.56 | 0.48 | 0.35 |
| Enterprise value to EBITDA |
|
9.73 | 11.56 | 14.58 | 9.49 | 9.56 |
| Enterprise value |
|
$166.59 B | $202.66 B | $180.05 B | $172.65 B | $130.85 B |
| Cash to Debt |
|
18.66% | 24.03% | 22.87% | 16.91% | 10.98% |
| Tax Rate (%) |
|
26.29% | 24.18% | 25.86% | 25.11% | 25.41% |
| Payout Ratio |
|
36.55% | 32.81% | 67.43% | 37.54% | 73.10% |
